Icatibant Injection is FDA-approved, so patients can be assured it is made with quality ingredients and is safe and effective. Fresenius Kabi’s generic option uses the same active ingredient as Firazyr®*, has the same intended use, and is also administered subcutaneously.
An important part of a successful Hereditary angioedema (HAE) treatment plan is support. Many patients have the support of their family, friends, and care team. Fresenius Kabi, a global healthcare company, developed KabiCare Patient Support Program. The KabiCare Patient Support Program offers financial assistance. Subject to eligibility requirements; available for both commercially insured and patients with no insurance coverage.
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion, clinical nutrition, and specialty pharmaceuticals. Our products and programs are designed to help care for critically and chronically ill patients.